chr3-180663915-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_181426.2(CCDC39):āc.162T>Cā(p.Ser54=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000856 in 1,612,186 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00049 ( 0 hom., cov: 32)
Exomes š: 0.000043 ( 1 hom. )
Consequence
CCDC39
NM_181426.2 synonymous
NM_181426.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0510
Genes affected
CCDC39 (HGNC:25244): (coiled-coil domain 39 molecular ruler complex subunit) The protein encoded by this gene is involved in the motility of cilia and flagella. The encoded protein is essential for the assembly of dynein regulatory and inner dynein arm complexes, which regulate ciliary beat. Defects in this gene are a cause of primary ciliary dyskinesia type 14 (CILD14). [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 3-180663915-A-G is Benign according to our data. Variant chr3-180663915-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 455012.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-180663915-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.051 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC39 | NM_181426.2 | c.162T>C | p.Ser54= | synonymous_variant | 2/20 | ENST00000476379.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC39 | ENST00000476379.6 | c.162T>C | p.Ser54= | synonymous_variant | 2/20 | 2 | NM_181426.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152206Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
75
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000105 AC: 26AN: 248470Hom.: 1 AF XY: 0.0000445 AC XY: 6AN XY: 134850
GnomAD3 exomes
AF:
AC:
26
AN:
248470
Hom.:
AF XY:
AC XY:
6
AN XY:
134850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000432 AC: 63AN: 1459862Hom.: 1 Cov.: 29 AF XY: 0.0000385 AC XY: 28AN XY: 726412
GnomAD4 exome
AF:
AC:
63
AN:
1459862
Hom.:
Cov.:
29
AF XY:
AC XY:
28
AN XY:
726412
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000492 AC: 75AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000416 AC XY: 31AN XY: 74496
GnomAD4 genome
AF:
AC:
75
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
31
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
CCDC39-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 06, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at